The UK’s Competition and Markets Authority has offered clearance to the proposed acquisition of AthroCare by Smith & Nephew, reports say, marking the final hurdle cleared in the parties’ efforts to finalize the deal.
The CMA concluded its Phase I investigation of the $1.7 billion medical technology merger. The companies had already secured approval from regulators in the US and Germany, according to reports.
Smith & Nephew’s acquisition aims to boost the company’s repair technology product portfolio, the company said, through AthroCare’s radio frequency expertise. The companies now expect to close the deal by May 29.
Stryker denies Smith & Nephew rumors
Clearance for Smith & Nephew’s acquisition came the same day US-based Stryker denied earlier reports that it plans to acquire Smith & Nephew’s orthopedic operations.
According to reports, the UK Takeover Panel requested an official statement from Stryker regarding the reports; the company cannot make a bid for Smith & Nephew for the next six months.
Full content: Health Point Capital and Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Turkey Fines Meta $10.4 Million for Abusing Market Dominance
May 6, 2024 by
CPI
Canadian Watchdog Launches Inquiry into Lululemon’s Greenwashing Practices
May 6, 2024 by
CPI
Massachusetts Supreme Court Deliberates Ballot Redefining Gig Worker Status
May 6, 2024 by
CPI
European Commission Approves Nippon Steel’s $14.9 Billion Buyout of U.S. Steel
May 6, 2024 by
CPI
Banco Sabadell Rejects Rival BBVA Merger Proposal
May 6, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI